Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis
CompletedNCT04402554
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients with inflammatory rheumatism very often have residual pain that is not easily relieved by conventional treatments. They can then use non-drug methods, such as physiotherapy, hypnosis or even cannabis. The aim of this study is to assess the percentage of patients who use cannabis to better relieve their pain or anxiety in chronic inflammatory rheumatism.
Study details
- Official title
- Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis
- Conditions
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Interventions
- Behavioral: Cannabis questionnaire
- Sponsor
- University Hospital, Clermont-Ferrand
- Start date
- 2020-05-19
- Primary completion
- 2021-03-19
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Rheumatoid Arthritis (ACR 2010 Criteria) * Ankylosing Spondylitis (New york or ASAS criteria) * Psoriatic Arthritis (CASPAR criteria) Exclusion Criteria: * Patient unable to complete questionnaires or unable to express informed consent * Guardianship, trusteeship, deprivation of liberties, safeguard of justice
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04402554